Thank you.
The production in Canada of non-adjuvanted vaccine was done in October. Before that, we had approached CSL Australia because during the summer it had been impossible to obtain non-adjuvanted vaccine from the manufacturers. They were all engaged in commitments made to other countries, and the only option for Canada was to obtain the non-adjuvanted vaccine from GlaxoSmithKline. In our case, this is a major advantage that most countries do not have. CSL Australia was able to supply the vaccine because its vaccination season is over down there. We had the option of buying vaccine once the season there had passed.
The non-adjuvanted vaccine was produced in October by GSK, after which four to six weeks were required to test the formulas and the methods in order to ensure the quality of the vaccine. These decisions were made a long time ago.